Back to discover
Disease
Tumor Virus Infections
Active therapeutic pipelineEmerging research
1
Publications
3
Clinical trials
2020
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
The landscape of viral associations in human cancers.
Research2020-02-05Nature genetics
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial expected to report results, the earliest in Q3 2027.
Upcoming Milestones
Major developments
Upcoming trial readoutHigh impact
Results expected Q3 20272026-07-17
Major clinical milestoneWorth watching
Primary completion2025-12-16
Clinical MilestonesViewHide
Results expected
- 2026-07-17A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)Results expected Q3 2027
Recently completed
Activity timeline2
- 2026-07-17ClinicalA Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)Results expected Q3 2027
- 2025-12-16ClinicalQuality of Life After Primary Transoral Robotic Surgery vs Intensity-modulated Radiotherapy for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma: A Randomized National TrialPrimary completion
Clinical trials
The current development programme across all trial phases.
Clinical programme
3
2
0
1
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Recent publications
Major themes2
- Transcriptome1
- Virus Integration1
Leading journals1
- Nature genetics1
Leading researchers8
- Alawi M1
- Borozan I1
- Brewer DS1
- Cooper CS1
- Desai N1
- Eils R1
- Ferretti V1
- Grundhoff A1
Affiliations (unnormalised)6
- Biomedical Data Science Laboratory1
- Center for Digital Health1
- Earlham Institute1
- German Cancer Research Center (DKFZ)1
- German Center for Infection Research (DZIF)1
- Heinrich-Pette-Institute1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.